The study, presented Saturday at a meeting of the American Heart Association in Chicago, is the first large trial to ...

Compared to warfarin, edoxaban was as effective -- or even more so -- in preventing stroke and blood clots, researchers said.

Hello Health Rounds Readers! Today we feature three more studies that were presented at one of the year's most important ...

People on blood thinners have a doubled risk of dangerous internal bleeding if they also take a non-steroidal ...

Prescribing anti-clotting medications to adults younger than age 65 who have atrial fibrillation (AFib) but no other risk ...

University of B.C. researchers have developed a groundbreaking coating that could make medical devices safer for millions of ...

Via Christi is the first hospital in the region to perform a new procedure for atrial fibrillation for patients who can’t ...

In the first large trial of its kind, the anti-clotting medication rivaroxaban did not lower the risk of cognitive decline ...

Researchers at the University of British Columbia have developed a groundbreaking coating that could make medical devices ...

Note: The study featured in this news release is a research abstract ... who had AFib but none of the standard risk factors that would necessitate the prescription of blood thinner medication. Half of ...

Fourteen percent of the world's people -- more than 800 million -- now have diabetes, a doubling of the global rate for the ...